Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Healthcare Management Webinars & Conferences

Europe & UK

Asia Pacific & Middle East



Welcome Message

The 12th International Conference on Clinical Research & Clinical Trials, with the theme "Futuristic Developments in Clinical Research & Clinical Trials," is scheduled for October 23-24, 2023 in London, UK. We cordially invite all dignitaries and sponsors from around the world to attend.
We cordially invite you to be a part of Euro Clinical Trials 2023, where you can be certain that you'll have the opportunity to speak with researchers from all around the world as needed.
Young scientists and researchers from all around the world would profit from having a platform to communicate their publications and opinions to eminent scientists, researchers, and academics about the same Euro Clinical Trials 2023. In the presence of our renowned members of the Organizing Committee, the Editorial Board Members showed an unparalleled level of curiosity.

About Conference

The 12th International Conference on Clinical Research & Clinical Trials is scheduled to take place in London, UK on October 23-24, 2023.
Keynote speeches, oral presentations, poster presentations, symposiums, workshops, exhibition, and career development events are all part of Euro Clinical Trails .
Conference Series Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals  which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conferences organize worldwide.
Euro Clinical Trials is one of the well-established conferences among Pharmaceutical Conferences Organized by Conference Series

Why to Attend

Give presentations, share knowledge, network with current and future scientists, make a splash with innovative developments in clinical research, and establish your name at this two-day conference. World-famous speakers, the most recent techniques, developments, and updates in clinical research, as well as encouragement of clinical research and clinical trials globally, are all features of the conference.
The transdisciplinary 2023 Euro Clinical Trials Conference draws attendees from all around the world who are eager to learn more about Euro Clinical Trials and its advancements. This is your best opportunity to present your work to the largest audience in the clinical trials, clinical research, and epidemiology communities, including academics, clinical research organizations, medical groups, affiliated associations, societies, and industry representatives from the pharmaceutical, biotech, and medical device sectors as well as governmental organizations..
It will educate medical professionals on clinical trial design, execution, organization, computing for research, regulatory issues, and reporting. The topic of pre-clinical research and the conduct of clinical trials will be covered by a number of disciplines at Euro Clinical Trials 2023. It promotes the general public to learn more about the value of clinical trials in the prevention, diagnosis, and treatment
At this 2-day event, give presentations, disseminate information, network with current and potential scientists, make a splash with novel advances in clinical research, and gain name recognition. The conference's characteristics include world-famous speakers, the most recent methods, advancements, and updates in clinical research, as well as encouragement of clinical research and clinical trials worldwide.

Who should attend and Who You’ll Meet

Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of
·         CROs and CMOs
·         Clinical Research Sites
·         Pharma/Biotech and Medical Device industries
·         Hospitals, Associations
·         Clinical research institutes
·         Societie
Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals along with Academicians: University Faculties like Directors, Senior Professors/Assistant Professors/ Associate Professor, Research Scholars, scientists who are related to clinical and medical research.
Young Scientist Benefits
·         Our conferences provide best Platform for your research through oral presentations.
·         Share the ideas with both eminent researchers and mentors.
·         Young Scientist Award reorganization certificate and memento to the winners
·         Young Scientists will get appropriate and timely information by this Forum.
·         Platform for collaboration among young researchers for better development
·         Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Session Tracks

Track 1: Clinical Research :
BIMO - Bioresearch Monitoring Program - The Food and Drug Administration (FDA) has a framework in place called the Bioresearch Monitoring Program (BIMO) to guarantee the safety of research participants and the reliability of clinical research data. The BIMO guidance manual provides guidelines for clinical researchers to adhere to in order to assure compliance.
CRF - Case Report Form - An electronic or paper questionnaire known as a case report form is used in clinical trial research to gather information from participants.
EDC - Electronic Data Capture - Clinical research professionals collect data using an electronic data capture technique on a digital platform. Data management is aided by an EDC platform, which enables researchers to gather, process, evaluates, and analyses data remotely. This helps speed up the time it takes for sponsors to bring devices to market.
GCP - Good Clinical Practice - All clinical research is built on the principles of good clinical practice (GCP). Everyone who participates in clinical studies will be given the protection they need thanks to this set of guiding principles.
Track 2: Clinical Trials :Refers to all or any research carried out on humans. It focuses on improving understanding of diseases, developing diagnostic methods and new treatments or medical devices to make sure better patient care. It’s much framed and a particular study protocol and is merely realized under certain conditions.Clinical trials are research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention
Track 3: Prevention trials :
Pharmacokinetics, measuring the effect of dose on rates of absorption and excretion of drugs from various body compartments;
Pharmacodynamics, measuring the intended or unintended effects of dose on physiologic measures;
Toxicology, measuring the effect of dose on histopathologic lesions in major organ systems;
Reproductive and embryologic effects as a function of dose
Track4: Screening Trials :
Finding out whether or if the screening test saves lives and at what cost is the objective. The techniques for identifying diseases
New tests for identifying cancer and other illnesses in people before symptoms appear are the subject of screening trials. Finding out whether or if the screening test saves lives and at what cost is the objective. The methods of illness detection are frequently
Diagnostic trials usually include people who have signs or symptoms of the disease or condition being studied. Refers to trials that are conducted to find better tests or procedures for diagnosing a particular disease or condition.
Research studies called "treatment trials" are carried out soon individuals with the goal of evaluating a medical, surgical, or behavioral intervention. They are the main method used by researchers to determine whether a new treatment, such as a new medication, diet, or medical gadget (such as a pacemaker), is safe and effective in humans.
devoted to enhancing the quality of life for those with serious or fatal diseases Supportive care aims to prevent or treat a disease's symptoms, side effects from its therapy, and any psychological, social, or spiritual issues that may be brought on by the disease or its treatment. Also known as symptom management, comfort care, and palliative care
Clinical trials are increasingly using endpoints related to health-related quality of life. Quality of life may be a big concern, particularly in diseases with a bad prognosis like metastatic cancer. But doctors are still hesitant to accept 
Epidemiologic studies have a wide range of applications, but they are most frequently used to calculate the prevalence of a disease and identify connections that could point to its origins. Measures of disease (incidence) or death (mortality) within population groupings are taken in order to meet these objectives.
Epidemiology is the study of how diseases and other health-related conditions are distributed among communities and the use of this knowledge to regulate health issues. Understanding the risk factors linked to various diseases is the goal of epidemiology. 
Expanded access refers to the administration of an investigational new medicine to patients for the diagnosis, observation, or treatment of a serious disease or condition outside of a clinical study. Contrarily, participants in clinical trials or studies—whether they are patients or healthy volunteers—are regarded as human subjects.
Expanded access may be necessary if all of the following hold true: Patient with a significant illness or condition, or whose illness or condition poses an imminent threat to their life. There is no alternative diagnosis method that is similar to or as effective.
Track9: Fixed trials
Fixed trials do not alter the trial after it has started, do not evaluate the outcomes until the study is complete, and only take into account available data during the trial's design.
A binomial experiment consists of three elements. There are always the same amounts of trials. Trials can be compared to iterations of an experiment. The number of trials is represented by the letter n. There are only two outcomes that are referred to be "success".”
Controlled clinical trials offer reliable data for science. Trials are, however, planned around a set of objectives and hypotheses in order to provide accurate information. In this session, we'll go over some fundamental design principles, unique trial management and data collection challenges brought on by the design, typical sorts of analysis, and the resultant statistical report.
A randomized controlled trial, also known as an RCT, is a type of scientific experiment (such as a clinical trial) or intervention study (in contrast to an observational study) that aims to reduce some sources of bias when testing the efficacy of new treatments. This is done by randomly assigning subjects to two or more groups, giving them different treatments, and then comparing them with respect to a measured response. The control group typically receives a different form of treatment, such as a placebo or no treatment, whereas the experimental group usually receives the intervention being evaluated to evaluate the effectiveness of the experimental intervention in contrast to the control, the groups are observed under the constraints of the trial design. There could be multiple treatment groups or multiple control groups.
Track12: Blind trial
An experiment is blinded or "blinded" if any information that might affect the participants is concealed until after the experiment is over. Experiment biases brought on by participant expectancies, observer effects on participants, observer bias, confirmation bias, and other factors can be lessened or even completely eliminated with effective blinding. Any participant in an experiment, including subjects, researchers, technicians, data analysts, and assessors, may be required to wear a blind. In some situations, blindness would be beneficial but is impractical or unethical. For instance, in a physical therapy session, it is not possible to blind a patient to their treatment. Blinding is made as efficient as possible within ethical and practical limitations by a solid therapeutic practice.
A sort of clinical trial in which information is not concealed from trial participants is an open-label trial, often known as an open trial. In particular, the subjects and researchers are both aware of the treatment being given. In contrast, a double-blinded study conceals information from both participants and researchers to lessen bias.
The evaluation of investigational therapies relies heavily on clinical studies. Clinical trial volunteers, investigators, and study coordinators are all essential to a trial's accomplishment. Clinical trials frequently employ a double-blind
Studies with the goal of evaluating interventions but without the use of randomization are known as quasi-experiments. Similar to randomized trials, the goal of quasi-experiments is to show that an intervention causes an effect.
This fundamental concept makes it clear that the quasi-experimental approach is used in a large number of published studies in medical informatics. Despite the fact that randomized controlled trials are typically regarded as having the highest level 
Nursing practice with a specialization on the treatment of study participants is known as clinical research nursing. Clinical research nurses play a crucial role in ensuring participant safety, continuing maintenance of informed consent, integrity of protocol implementation, accuracy of data collecting, data recording, and follow-up, in addition to delivering and organizing clinical care. The care that research participants receive is determined by the needs of the study, the gathering of research data, and clinical indications.
Significant and current publications in the areas of experimental and clinical oncology are published in the "Journal of Cancer Research and Clinical Oncology." In addition to Original pieces, the journal also publishes Reviews and Editor's Notes.
The MHRA (Medicines and Healthcare Regulatory Agency) tests new and/or existing medications for various conditions. The study can evaluate the appropriate dosages, the efficacy of the treatment in a population, the pharmacodynamics and pharmacokinetic aspects of the drug's action within the body, and any unfavorable side effects. This makes it possible for trial drugs to be understood better and gives patients more access to medications for a particular ailment.
Pharmaceutical businesses do clinical studies all over the world to assess the efficacy and safety of their products. To get regulatory approval and make the treatments available to patients, these studies are a prerequisite
Clinical Research on Pathology, with a focus on tissue-based investigations but not exclusively, acts as a translational link between basic biomedical science and clinical medicine. Clinical Pathology Research investigations on biomarkers, diagnostics, and prognosis that have a strong clinical focus and further our understanding of the mechanisms underlying human disease. Studies that are hypothesis-driven, well powered, and validated will often be favored.
At every stage of a clinical study, from design and participant recruiting through to result analysis and continuous monitoring and evaluation, pathologists can be extremely helpful. As the era of precision medicine begins, where medicines are Related Conference on Clinical Pathology Research
Track 19: Clinical Trail in Nutrients
There is a need for dietary intervention studies in a variety of preventive and therapeutic health and disease states. This urgent need has been brought about by the advent of chronic non-communicable disease (CNCD), which has a recognized nutritional A etiology, as well as additional illnesses that weren't previously thought to have a nutritional basis. These include age-related health issues like the menopause, immune system deterioration, and cognitive impairment. New food exposures and the long-term impacts of nutritionally mediated gene expression are related to a new set of materno-fetal and infant nutrition concerns that need to be investigated.
There is a need for dietary intervention studies in a variety of preventive and therapeutic health and disease states.
The foundation of well-managed trials is strong project management, employee training, quality control monitoring, and internal audits. This session will discuss trial management and control issues within the framework of a comprehensive system. There is a practical activity at the end of the module.
Any multi-step process must be completed with discipline, coordination, and organization. Naturally, doing a clinical experiment is similar. There are constantly a lot of moving parts, and sound planning and communication are essential.

Market analysis

The worldwide clinical trials advertise estimate was esteemed at USD 40.0 billion of every 2016 and is relied upon to develop at a CAGR of 5.7% over the gauge time frame. Key drivers affecting the market development are globalization of clinical trials, improvement of new medications, for example, customized prescription, expanding advancement in innovation, and boosting interest for CROs to lead clinical trials. CROs enhanced mastery when contrasted with pharma organizations concerning performing clinical trials in wide exhibit of topographies and advancement of medications in particular restorative zones are few components in charge of the developing interest for the CROs in pharmaceutical section. As indicated by Bio Outsource, the interest for biosimilar testing is required to increment in the U.S. This is credited to the way that the FDA at long last began tending to the absence of clear direction with respect to biosimilar, particularly how the engineers ought to demonstrate that their medications are like that of the originator item. In January 2015, Hospital submitted one of the biosimilar renditions of Apogent and the consequence of the survey in the U.S. is expected from the FDA inside a year. 
The land dispersion of clinical trials is gradually moving from created countries to rising nations. The increasing expense of clinical trials and trouble in persistent enrolment has driven biopharmaceutical organizations to move towards locales, for example, focal and Eastern Europe, Asia Pacific, Latin America and Middle-East for cost proficiency and snappy patient recruitment. Emerging nations likewise have more prominent malady variety contrasted with west, where conventional infections are developing. The more prominent malady variety among the creating nations encourages biopharmaceutical organizations to perform clinical trials from uncommon sicknesses. Digitization in biomedical research is preparing for development of worldwide clinical trial showcase. Selection of Systems like EDC is additionally helping organizations to better deal with their patient information which eventually lessens the observing expense and help in better patient consistence. Digitization likewise helps in meeting the stringent directions by keeping up tolerant information records which at last aides in decreasing clinical trials process mistakes.

Target Audience

Target Audience:

CRO’s, Pharmacy professionals, Association chiefs and Pharma Business people. Professors, Students and to provide an international forum for the spread of original research results, new ideas and practical development experiences which concentrate on both theory and practices, CEO's and Scientists, R & D Professionals

Industry        50%

Researchers   20%

Academia     20%

Others          10%

Target Audience Analysis

Past Conference Report

Clinical Research 2022

28th International Conference on Advanced Clinical Research and Clinical Trials
Conference series hosted 28th International Conference on Advanced Clinical Research and Clinical Trials November 14-15, 2022/webinar.
 Active participation and generous response were received from the Organizing Committee Members, scientists, researchers, as well as experts from Non-government organizations, and students from diverse groups who made this conference as one of the most successful and productive events in 2020 from Conference series.
The conference was marked with several workshops, multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from scientists, young and brilliant researchers, business delegates and talented student communities representing more than 35 countries, who have driven this event into the path of success.
The conference was initiated with a warm welcome note by Honorable guests and the Keynote forum. The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:
We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Clinical Research 2020 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, Conference Series would like to announce the commencement of “29th International Conference on Advanced Clinical Research and Clinical Trials


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date October 23-24, 2023

Speaker Opportunity

Supported By

Clinical Investigation Clinical Research on Foot & Ankle Clinical Pharmacology & Biopharmaceutics

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by